Biblio
Export 223 results:
[ Author] Title Type Year Filters: First Letter Of Title is E [Clear All Filters]
“The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.”, J Alzheimers Dis, vol. 70, no. 3, pp. 861-875, 2019.
, “Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly.”, J Alzheimers Dis, vol. 55, no. 1, pp. 293-301, 2017.
, “Ethnic Differences in Dementia Risk: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 80, no. 1, pp. 337-355, 2021.
, “Everyday Memory in Patients with Alzheimer's Disease: Fragmentary and Distorted.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1489-1498, 2017.
, “The Efficacy and Safety of Physiotherapy in People with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 94, no. 3, pp. 909-917, 2023.
, “Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
, “Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps.”, J Alzheimers Dis, vol. 92, no. 1, pp. 13-27, 2023.
, “Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.”, J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
, “Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 1, pp. 19-25, 2016.
, “Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb.”, J Alzheimers Dis, vol. 49, no. 2, pp. 443-57, 2016.
, “Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.”, J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
, “Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 62, no. 1, pp. 467-476, 2018.
, “Effect of Normal Aging and of Mild Cognitive Impairment on Event-Related Potentials to a Stroop Color-Word Task.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1487-501, 2016.
, “Exercise-Related Physical Activity Relates to Brain Volumes in 10,125 Individuals.”, J Alzheimers Dis, vol. 97, no. 2, pp. 829-839, 2023.
, “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
, “The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.”, J Alzheimers Dis, vol. 50, no. 3, pp. 895-905, 2016.
, “Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 3, pp. 1017-1037, 2024.
, “The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1517-1529, 2018.
, “Effect of Early Referral to Specialist in Dementia on Institutionalization and Functional Decline: Findings from a Population-Based Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 819-28, 2016.
, “Effects of Healthy Aging and Mild Cognitive Impairment on a Real-Life Decision-Making Task.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1077-1087, 2017.
, “Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1599-1609, 2018.
, “Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1379-1385, 2017.
, “Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 615-624, 2017.
, “Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 58, no. 3, pp. 725-733, 2017.
, “Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
,